Nafi Pharmaceuticals is a biotechnology startup founded in 2019 that focuses on developing innovative medications for central nervous system illnesses. With a slogan that emphasizes their commitment to creating groundbreaking treatments, Nafi Pharmaceuticals has garnered attention from investors in the health care industry. The company recently secured a Series A investment on 21 September 2023, with funding coming from Kaitai Capital and Yael Capital Management Limited. This investment underscores the confidence that these prominent investors have in the potential of Nafi Pharmaceuticals' developments and their ability to make a significant impact within the healthcare sector.
Nafi Pharmaceuticals
Nafi Pharmaceuticals develops novel medications for central nervous system illnesses.
Founded 2019
Series A
Total: $15.00M
Biotechnology, Health Care
General Information
Company Name
Nafi Pharmaceuticals
Founded Year
2019
Industries
Biotechnology, Health Care
Funding Stage
Series A
BounceWatch is an independent company data service, not affiliated with Nafi Pharmaceuticals. To contact Nafi Pharmaceuticals, visit nasal-phyto.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
Discover More
About Nafi Pharmaceuticals
Funding Rounds & Investors (3)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series A | Undisclosed | 2 |
|
21 Sep 2023 |
| Seed Round | Undisclosed | 1 |
|
21 Oct 2021 |
| Seed Round | CNY15.00M | - |
|
21 Feb 2020 |
Nafi Pharmaceuticals Alternatives & Competitors
View All Alternatives
Nafi Pharmaceuticals vs
Neurolixis
United States
New treatments for central nervous system disorders
Seed
5 employees
Biopharma, Biotechnology
Nafi Pharmaceuticals vs
Innovative Approaches to Therapy for Central Nervous System Diseases
Venture round
2 employees
Biotechnology, Health Care
Nafi Pharmaceuticals vs
Psy Therapeutics
United States
Creating new futures in central nervous system (CNS) treatment and care.
Seed
11 employees
Biotechnology, Health Care
FAQ About Nafi Pharmaceuticals
Nafi Pharmaceuticals develops novel medications for central nervous system illnesses.
Nafi Pharmaceuticals was founded in 2019.
Nafi Pharmaceuticals operates in Biotechnology and Health Care.
Nafi Pharmaceuticals has completed 3 funding rounds, raising a total of $15.00M. The latest funding stage is Series A.
Top alternatives and competitors to Nafi Pharmaceuticals include Neurolixis, Gene Solutions, Psy Therapeutics, nVector, Inc, Emalex Biosciences. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Nafi Pharmaceuticals and Neurolixis are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Source: BounceWatch company record for Nafi Pharmaceuticals, https://bouncewatch.com/company/nafi-pharmaceuticals, updated 27 October 2024. When citing, please name BounceWatch and link this page.
